Search Results 131-140 of 16992 for Antagonist
TNFα Antagonists;. Active disease despite a history of at least one induction regimen of a TNFα Antagonist: Infliximab: Minimum induction regimen of 5 mg/kg ...
Furthermore, a maximal synergetic effect was achieved when a FAK inhibitor was given in combination with a PD-1 antagonist and chemotherapy in multiple pancreas ...
buserelin, triptorelin) or LHRH antagonist (e.g. degarelix), anti-androgens (e.g., flutamide, bicalutamide, cyproterone acetate), estrogens (e.g., DES), or
... antagonist therapies. Mayo presenters at DDW also discussed their work describing the genetic risk burden affecting patients with IBD and perianal disease ...
... antagonist, and interleukin 5 receptor antagonist following endoscopic sinus surgery versus control in patient with chronic sinusitis with nasal polyps and ...
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...
This noncancerous tumor can sometimes grow on the nerve in the head that affects hearing and balance.
Spinal cord tumors can cause serious problems such as pain and paralysis. Find out how more about management and treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.